Eviti^®

Before treatment begins, at the point of prescription. That timing is the whole point. Validating after the fact produces denials and appeals, while validating at the decision produces an answer the oncologist can act on immediately.

It routes to clinical review rather than being denied. The portal shows which criterion triggered the review and the payer's regimen preference, and supporting documentation can be attached to the same case. Plans that align with nationally accepted standards are authorized automatically.

Board-certified oncologists, radiation therapists, oncology-certified nurses, and clinical informatics professionals. NantIQ^® holds no financial interest in the drugs or regimens displayed, which is what makes the library usable as a neutral reference by both plans and prescribers.

Eviti^® Connect is the utilization management platform that connects plans and practices to validate and authorize treatment. Eviti^® Advisor is the clinical decision support tool for oncologists. It is a library of 4,800+ evidence-based regimens and 9,500+ federally registered clinical trials, compared side by side on evidence level, outcomes, cost, and toxicity. They integrate, so a plan chosen in Advisor aligns with what Connect will authorize.

Eviti^® Connect for Oncology customers have reported a 6:1 return. Eviti^® has found evidence-based care for more than 345,000 cancer patients and saved payers hundreds of millions of dollars. It is HITRUST certified and NCQA accredited.